| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P50 | author | Zbys Fedorowicz | Q28036367 |
| Esther J van Zuuren | Q38546299 | ||
| P2093 | author name string | Ben Carter | |
| Mireille M D van der Linden | |||
| Lyn Charland | |||
| P2860 | cites work | Clinical and laboratory study of ocular rosacea in northern Greece | Q83512988 |
| Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea | Q84522659 | ||
| Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study | Q85036362 | ||
| Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea | Q87252286 | ||
| Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea | Q87414425 | ||
| [Rosacea. Clinical features and treatment] | Q93518842 | ||
| Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies | Q95373972 | ||
| Randomized, phase 2, dose-ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gel | Q95406151 | ||
| Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea | Q95406153 | ||
| Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay Thermal spring water as monotherapy or adjunctive therapy | Q95415898 | ||
| Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study | Q95513123 | ||
| Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies | Q95524892 | ||
| Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea | Q95583433 | ||
| Topical antifungal treatments for tinea cruris and tinea corporis | Q24194482 | ||
| Interventions for female pattern hair loss | Q24197667 | ||
| Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item | Q24201550 | ||
| Interventions for rosacea | Q24235769 | ||
| Interventions for rosacea | Q24246629 | ||
| Interventions for rosacea | Q24247666 | ||
| Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin | Q24568006 | ||
| Rosacea: a review | Q24658459 | ||
| Clonidine and facial flushing in rosacea | Q24675275 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease | Q27002345 | ||
| Rosacea as a disease of cathelicidins and skin innate immunity | Q27025543 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea | Q28239417 | ||
| Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link | Q28250993 | ||
| Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials | Q28259219 | ||
| Incyclinide | Q29398227 | ||
| Rosacea: where are we now? | Q31070830 | ||
| Efficacy of 1% 4-ethoxybenzaldehyde in reducing facial erythema. | Q33219936 | ||
| Laser and light therapies for acne rosacea. | Q33233493 | ||
| A system for rating the stability and strength of medical evidence | Q33260932 | ||
| A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema | Q33281922 | ||
| Mite-related bacterial antigens stimulate inflammatory cells in rosacea. | Q33289069 | ||
| Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation | Q33322380 | ||
| Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser | Q33328242 | ||
| The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results | Q33369928 | ||
| Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea | Q81474214 | ||
| Results of a national rosacea patient survey: common issues that concern rosacea sufferers | Q83336818 | ||
| Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea | Q83361207 | ||
| A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial | Q44659571 | ||
| Continuous 'microdose' isotretinoin in adult recalcitrant rosacea | Q44778629 | ||
| Lack of 'appropriately assessed' patient-reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea | Q44817495 | ||
| Oral use of azithromycin for the treatment of acne rosacea | Q44850988 | ||
| Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea | Q44874554 | ||
| Therapeutic potential of azithromycin in rosacea | Q44882326 | ||
| Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea | Q45113293 | ||
| An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes | Q45153232 | ||
| Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents | Q45206561 | ||
| The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. | Q45280072 | ||
| Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea | Q45377637 | ||
| A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea | Q45805143 | ||
| A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial. | Q45931289 | ||
| A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. | Q45934425 | ||
| Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam. | Q46095104 | ||
| Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin | Q46105461 | ||
| Adapalene vs. metronidazole gel for the treatment of rosacea. | Q46419556 | ||
| Comparative study of some treatment modalities of rosacea | Q46427781 | ||
| Perolen cream for therapy of rosacea | Q46459016 | ||
| Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms? | Q46460454 | ||
| Pimecrolimus for treatment of acne rosacea | Q46488227 | ||
| Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea | Q46534128 | ||
| Clinical efficacy of tacrolimus in rosacea | Q46580258 | ||
| Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea | Q46621853 | ||
| Rosacea/acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment | Q46627733 | ||
| Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial | Q46684617 | ||
| Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. | Q46738915 | ||
| Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial. | Q46742158 | ||
| Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation | Q46768478 | ||
| Azithromycin in the treatment of papulopustular rosacea | Q46856745 | ||
| Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline | Q46891705 | ||
| Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone | Q47802245 | ||
| Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies | Q48084046 | ||
| Efficacy of topical cyclosporine for the treatment of ocular rosacea | Q48422815 | ||
| Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea | Q48465170 | ||
| A community-based study of the effectiveness of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea | Q48710052 | ||
| An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. | Q50704469 | ||
| Reliability of Clinician Erythema Assessment grading scale. | Q51816438 | ||
| A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea. | Q52546943 | ||
| Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. | Q52600110 | ||
| Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. | Q52779057 | ||
| A pilot study in discrepancies in quality of life among three cutaneous types of rosacea. | Q53076284 | ||
| Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. | Q53482598 | ||
| Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. | Q54130283 | ||
| Comparative effectiveness of tetracycline and ampicillin in rosacea. A controlled trial. | Q54320846 | ||
| Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy? | Q54540024 | ||
| A clinical trial of tetracycline in rosacea. | Q54781353 | ||
| The use and safety of doxycycline hyclate and other second-generation tetracyclines. | Q55050505 | ||
| Oxidative stress and ferritin expression in the skin of patients with rosacea | Q61167768 | ||
| Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea | Q61631775 | ||
| Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea | Q33435597 | ||
| Quality of life and rosacea: pulsed dye laser impact | Q33450787 | ||
| Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser | Q33502238 | ||
| Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial | Q33537304 | ||
| Acne rosacea: effectiveness of 532 nm laser on the cosmetic appearance of the skin | Q33578473 | ||
| Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trial. | Q33766490 | ||
| Acne and rosacea. New and emerging therapies | Q33811508 | ||
| Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea | Q33978429 | ||
| Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color | Q34003548 | ||
| An epidemiological study of rosacea. | Q34043278 | ||
| Ocular rosacea: common and commonly missed | Q34384988 | ||
| Rosacea: new and emerging treatments. | Q34434971 | ||
| Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea | Q34560845 | ||
| Evaluation of topical metronidazole gel in acne rosacea | Q34562851 | ||
| New insights into rosacea pathophysiology: a review of recent findings. | Q34657462 | ||
| The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessment | Q34695799 | ||
| A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea | Q34727391 | ||
| Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: A double-blind randomized controlled trial | Q34729237 | ||
| Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. | Q34775867 | ||
| Hydrophobically modified polymers can minimize skin irritation potential caused by surfactant-based cleansers | Q34844455 | ||
| Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices | Q35113682 | ||
| Measuring the severity of rosacea: a review | Q35145238 | ||
| Effect of nadolol on flushing reactions in rosacea. | Q35250522 | ||
| Subantimicrobial dose doxycycline for acne and rosacea | Q35606925 | ||
| Oral tetracyclines for ocular rosacea: an evidence-based review of the literature | Q35618906 | ||
| Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea | Q35823265 | ||
| Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema | Q35862114 | ||
| Clinical practice. Rosacea | Q36053377 | ||
| Rosacea: the battle goes on. | Q36131800 | ||
| Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea | Q36369006 | ||
| Tetracyclines: nonantibiotic properties and their clinical implications | Q36380200 | ||
| Oral therapy for rosacea | Q36391963 | ||
| Systematic review of rosacea treatments | Q36693104 | ||
| Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. | Q36991412 | ||
| Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. | Q37013298 | ||
| The enigma of rosacea | Q37024089 | ||
| Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea | Q37309955 | ||
| Current topical and systemic approaches to treatment of rosacea | Q37512383 | ||
| Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor | Q37676098 | ||
| The role of tetracyclines in rosacea | Q37689115 | ||
| Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group | Q37768487 | ||
| Rosacea and its ocular manifestations | Q37833194 | ||
| Optimal management of papulopustular rosacea: rationale for combination therapy | Q38024979 | ||
| An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea | Q38119969 | ||
| Rosacea: current state of epidemiology | Q38162509 | ||
| Emerging therapies in rosacea | Q38162511 | ||
| The quality of life impact of acne and rosacea compared to other major medical conditions | Q38219463 | ||
| The psychological impact of rosacea and the influence of current management options. | Q38226105 | ||
| Health-related quality of life in patients with cutaneous rosacea: a systematic review | Q38255714 | ||
| Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial. | Q38453613 | ||
| Preparation and evaluation of topical microemulsion system containing metronidazole for remission in rosacea | Q39246474 | ||
| Treatment of rosacea by metronidazole | Q39382438 | ||
| Efficacy of doxycycline and tetracycline in ocular rosacea. | Q39492430 | ||
| A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks. | Q39644069 | ||
| Comparative Study of Triamcinolone Acetonide and Hydrocortisone 17-Butyrate in Rosacea with Special Regard to the Rebound Phenomenon | Q39779511 | ||
| Topical metronidazole maintains remissions of rosacea | Q42541387 | ||
| Oxytetracycline in the treatment of ocular rosacea: a double-blind trial | Q42608648 | ||
| The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life. | Q42668195 | ||
| Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea | Q42964743 | ||
| The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities | Q43025493 | ||
| Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study | Q43118831 | ||
| Rosacea - S1 guideline. | Q43506431 | ||
| Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum | Q44012386 | ||
| Effect of treatment of Helicobacter pylori infection on rosacea | Q44056847 | ||
| Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea | Q44452882 | ||
| Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies | Q44467246 | ||
| A multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea | Q44649147 | ||
| Interventions for acne rosacea | Q61636284 | ||
| Standardized skin surface biopsy: method to estimate the Demodex folliculorum density, not to study the Demodex folliculorum prevalence. | Q64925300 | ||
| Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements. | Q65002760 | ||
| Treatment of rosacea with tetracycline and metronidazole--a comparative study | Q67299918 | ||
| Oral spironolactone therapy in male patients with rosacea | Q67546294 | ||
| [Dimensions of the sample and power of the clinical experimentation in a study of antibiotic therapy] | Q68446405 | ||
| New topical therapy for acne rosacea offers conspicuous improvement, no systemic effects | Q69296124 | ||
| Topical metronidazole in the treatment of rosacea | Q70014895 | ||
| Topical metronidazole therapy for rosacea | Q70029475 | ||
| [Metronidazole cream for the local treatment of rosacea] | Q70056240 | ||
| A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea | Q70527644 | ||
| Treatment of rosacea: topical clindamycin versus oral tetracycline | Q70542605 | ||
| Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness | Q71695967 | ||
| The efficacy of topical metronidazole in the treatment of ocular rosacea | Q71833027 | ||
| Rosacea. Pathophysiology and treatment | Q72295794 | ||
| [Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea] | Q72608120 | ||
| Topical treatment with sulfur 10 per cent for rosacea | Q72752189 | ||
| Alcohol-induced rosacea flushing blocked by naloxone | Q72761619 | ||
| Treatment of rosacea with 1% metronidazole cream. A double-blind study | Q72778746 | ||
| Acne rosacea. Efficacy of a metronidazole cream | Q72786080 | ||
| The relapse rate for rosacea after treatment with either oral tetracycline or metrondazole cream | Q72787208 | ||
| A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea | Q72787220 | ||
| Topical treatment of acne rosacea with benzoyl peroxide acetone gel | Q72794746 | ||
| Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea | Q73274164 | ||
| Rosacea: classification and treatment | Q73307313 | ||
| Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea | Q74054139 | ||
| A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea | Q74183426 | ||
| Clarithromycin versus doxycycline in the treatment of rosacea | Q74183799 | ||
| Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea | Q74632056 | ||
| The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial | Q77303855 | ||
| [Rilmenidine in rosacea: a double-blind study versus placebo] | Q77311013 | ||
| [Treatment of rosacea. Clonidine (0.075 mg per day) versus placebo (initial results)] | Q77311112 | ||
| Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea | Q77801968 | ||
| A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea | Q77872460 | ||
| Childhood stye and adult rosacea | Q79347813 | ||
| Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea | Q79970742 | ||
| Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study | Q79971962 | ||
| An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption | Q79993561 | ||
| A pilot quality-of-life instrument for acne rosacea | Q80185858 | ||
| Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15% | Q80329417 | ||
| Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea | Q80407394 | ||
| Treatment of rhinophyma with the Versajet Hydrosurgery System | Q80679806 | ||
| Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea | Q80718659 | ||
| Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system | Q80859772 | ||
| Elevated expression and activation of matrix metalloproteinase 8 in tear fluid in atopic blepharoconjunctivitis | Q80943976 | ||
| Measurement of the severity of rosacea | Q80953350 | ||
| A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea | Q81389641 | ||
| P433 | issue | 4 | |
| P304 | page(s) | CD003262 | |
| P577 | publication date | 2015-04-28 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Interventions for rosacea |
| Q30238647 | Acne and Rosacea |
| Q39015138 | Aktueller Stand der systemischen Rosazea-Therapie |
| Q41089700 | An empirically generated responder definition for rosacea treatment |
| Q33885522 | An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations |
| Q54936170 | An update on the treatment of rosacea. |
| Q36024801 | Canadian Clinical Practice Guidelines for Rosacea |
| Q47239875 | Characterization of the facial microbiome in twins discordant for rosacea. |
| Q92055255 | Coronavirus-Days in Dermatology |
| Q27332058 | Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey |
| Q64271583 | Effect of recombinant bovine basic fibroblast growth factor gel on repair of rosacea skin lesions: A randomized, single-blind and vehicle-controlled study |
| Q58759097 | Effects of dextran sulfate, 4-t-butylcyclohexanol, pongamia oil and hesperidin methyl chalcone on inflammatory and vascular responses implicated in rosacea |
| Q36999979 | Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis |
| Q28077479 | Improving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical Features |
| Q57689523 | Interventions for Old World cutaneous leishmaniasis |
| Q46250558 | Interventions for Old World cutaneous leishmaniasis. |
| Q90751280 | Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments |
| Q53693112 | Oral doxycycline for the prevention of postoperative trachomatous trichiasis in Ethiopia: a randomised, double-blind, placebo-controlled trial. |
| Q55365607 | Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study. |
| Q91879800 | Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews |
| Q39015150 | Rosacea Management: Update on general measures and topical treatment options |
| Q50324762 | Rosacea: Epidemiology, pathogenesis, and treatment. |
| Q28069553 | Rosacea: a Clinical Review |
| Q39015131 | Rosazea-Management: Update über allgemeine Maßnahmen und topische Therapieoptionen |
| Q39015135 | State of the art: systemic rosacea management |
| Q46639991 | Subantimicrobial-dose doxycycline monohydrate in dermatology. |
| Q37150175 | Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study |
| Q37116294 | The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis |
| Q50110517 | Therapeutic inhibitors for the treatment of dry eye syndrome |
| Q64988298 | Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations. |
| Q92277510 | Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS) |
Search more.